90 related articles for article (PubMed ID: 2825982)
41. Linker length in podophyllotoxin-acridine conjugates determines potency in vivo and in vitro as well as specificity against MDR cell lines.
Rothenborg-Jensen L; Hansen HF; Wessel I; Nitiss JL; Schmidt G; Jensen PB; Sehested M; Jensen LH
Anticancer Drug Des; 2001 Dec; 16(6):305-15. PubMed ID: 12375883
[TBL] [Abstract][Full Text] [Related]
42. Effect of sodium chloride concentration on adriamycin and N-trifluoroacetyladriamycin-14-valerate (AD32)-induced cell killing and DNA damage in Chinese hamster V79 cells.
Iliakis G; Lazar W
Cancer Res; 1987 Apr; 47(7):1853-8. PubMed ID: 3815376
[TBL] [Abstract][Full Text] [Related]
43. Verapamil and cyclosporin A modulate doxorubicin toxicity by distinct mechanisms.
Shoji Y; Fisher MH; Periasamy A; Herman B; Juliano RL
Cancer Lett; 1991 May; 57(3):209-18. PubMed ID: 2032209
[TBL] [Abstract][Full Text] [Related]
44. Protective effect of ouabain on adriamycin-induced cardiovascular anomalies in chick embryos.
Takagi Y; Bruyere HJ; Nishikawa T
Teratology; 1989 Jun; 39(6):573-80. PubMed ID: 2772843
[TBL] [Abstract][Full Text] [Related]
45. Inhibition of DNA topoisomerases I and II, and growth inhibition of breast cancer MCF-7 cells by ouabain, digoxin and proscillaridin A.
Bielawski K; Winnicka K; Bielawska A
Biol Pharm Bull; 2006 Jul; 29(7):1493-7. PubMed ID: 16819197
[TBL] [Abstract][Full Text] [Related]
46. Lack of effect of glutathione depletion on cytotoxicity, mutagenicity and DNA damage produced by doxorubicin in cultured cells.
Capranico G; Babudri N; Casciarri G; Dolzani L; Gambetta RA; Longoni E; Pani B; Soranzo C; Zunino F
Chem Biol Interact; 1986 Feb; 57(2):189-201. PubMed ID: 3955790
[TBL] [Abstract][Full Text] [Related]
47. DNA damage and cytotoxicity induced by metabolites of anthracycline antibiotics, doxorubicin and idarubicin.
Ferrazzi E; Woynarowski JM; Arakali A; Brenner DE; Beerman TA
Cancer Commun; 1991 Jun; 3(6):173-80. PubMed ID: 2049226
[TBL] [Abstract][Full Text] [Related]
48. Comparison of intracellular drug retention, DNA damage and cytotoxicity of derivatives of doxorubicin and daunorubicin in a human colon adenocarcinoma cell line (LoVo).
Belvedere G; Suarato A; Geroni C; Giuliani FC; D'Incalci M
Biochem Pharmacol; 1989 Nov; 38(21):3713-21. PubMed ID: 2557027
[TBL] [Abstract][Full Text] [Related]
49. The effect of ultrasound on the cytotoxicity of adriamycin.
Loverock P; ter Haar G; Ormerod MG; Imrie PR
Br J Radiol; 1990 Jul; 63(751):542-6. PubMed ID: 2390688
[TBL] [Abstract][Full Text] [Related]
50. Ouabain sensitizes tumor cells but not normal cells to radiation.
Lawrence TS
Int J Radiat Oncol Biol Phys; 1988 Oct; 15(4):953-8. PubMed ID: 3182336
[TBL] [Abstract][Full Text] [Related]
51. Survival of rat mammary tumor cell clones and DNA strand damage following adriamycin treatment.
Evans DP; Meyn RE; Tomasovic SP
Cancer Chemother Pharmacol; 1986; 18(2):137-9. PubMed ID: 3791558
[TBL] [Abstract][Full Text] [Related]
52. Adriamycin uptake, intracellular binding and cytotoxicity in Chinese hamster ovary cells.
Bates DA; Fung H; Mackillop WJ
Cancer Lett; 1985 Sep; 28(2):213-21. PubMed ID: 4052991
[TBL] [Abstract][Full Text] [Related]
53. [Effects of adriamycin and daunomycin on myocardial cells cultured in vitro].
Necco A; Dasdia T
G Ital Chemioter; 1975; 22(1-2):15-8. PubMed ID: 1235346
[No Abstract] [Full Text] [Related]
54. Comparison of DNA scission and cytotoxicity produced by Adriamycin and 5-iminodaunorubicin in human colon carcinoma cells.
Johnston JB; Zwelling LA; Kerrigan D; Lloyd LS; Glazer RI
Biochem Pharmacol; 1983 Jul; 32(14):2255-8. PubMed ID: 6870948
[TBL] [Abstract][Full Text] [Related]
55. Adriamycin uptake in V79 and adriamycin resistant Chinese hamster cells.
Harris JR; Timberlake N; Henson P; Schimke P; Belli JA
Int J Radiat Oncol Biol Phys; 1979 Aug; 5(8):1235-9. PubMed ID: 528269
[No Abstract] [Full Text] [Related]
56. Transmembrane ion flux modifiers verapamil and ouabain modulate cytotoxic effects of extracellular ATP on human tumor-cells in-vitro.
Correale P; Caraglia M; Procopio A; Marinetti M; Guarrasi R; Fabbrocini A; Bianco A; Tagliaferri P
Int J Oncol; 1993 Nov; 3(5):847-51. PubMed ID: 21573442
[TBL] [Abstract][Full Text] [Related]
57. Comparative effects of doxorubicin and 4'-epi-doxorubicin on nucleic acid metabolism and cytotoxicity in a human tumor cell line.
Cantoni O; Sestili P; Cattabeni F; Geroni C; Giuliani F
Cancer Chemother Pharmacol; 1990; 27(1):47-51. PubMed ID: 1700932
[TBL] [Abstract][Full Text] [Related]
58. Action of ouabain, oligomycin, and glucagon on cultured heart cells treated with adriamycin.
Necco A; Dasdia T; Di Francesco D; Ferroni A
Pharmacol Res Commun; 1976 Feb; 8(1):105-9. PubMed ID: 1026950
[No Abstract] [Full Text] [Related]
59. Factors affecting the repair of sublethal freeze-thaw damage in mammalian cells. II. The effect of ouabain.
McGann LE; Kruuv J; Frim J; Frey HE
Cryobiology; 1974 Aug; 11(4):332-9. PubMed ID: 4477057
[No Abstract] [Full Text] [Related]
60. Doxorubicin (adriamycin): a critical review of free radical-dependent mechanisms of cytotoxicity.
Keizer HG; Pinedo HM; Schuurhuis GJ; Joenje H
Pharmacol Ther; 1990; 47(2):219-31. PubMed ID: 2203071
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
